Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Collegium Pharmaceutical (COLL) over the last 9 years, with Q3 2025 value amounting to $2.85.

  • Collegium Pharmaceutical's Times Interest Earned rose 5059.57% to $2.85 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.83, marking a year-over-year decrease of 3313.24%. This contributed to the annual value of $2.3 for FY2024, which is 1463.96% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Times Interest Earned stood at $2.85 for Q3 2025, which was up 5059.57% from $1.72 recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Times Interest Earned ranged from a high of $3.7 in Q1 2021 and a low of -$7.17 during Q4 2021
  • Moreover, its 5-year median value for Times Interest Earned was $1.72 (2025), whereas its average is $1.37.
  • Per our database at Business Quant, Collegium Pharmaceutical's Times Interest Earned plummeted by 47008.25% in 2021 and then soared by 45990.51% in 2023.
  • Collegium Pharmaceutical's Times Interest Earned (Quarter) stood at -$7.17 in 2021, then skyrocketed by 107.97% to $0.57 in 2022, then surged by 459.91% to $3.2 in 2023, then crashed by 47.42% to $1.68 in 2024, then surged by 69.55% to $2.85 in 2025.
  • Its last three reported values are $2.85 in Q3 2025, $1.72 for Q2 2025, and $1.04 during Q1 2025.